Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
PTSD in young people 'wake-up call'
Fri Feb 22nd - One in 13 young people in the UK has suffered post-traumatic disorder – and almost one third has had a traumatic experience – before they reach the age of 18, the first UK study of its kind reports today. More
Salt behind some allergic immune reactions
Fri Feb 22nd - Salt could be one of the reasons why some people develop allergic immune reactions, according to a new German study. More
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
guide to breast disorders guide to womb disorders guide to menopause Complete Women's Health: from The Royal College of Obstetricians and Gynaecologists For books and family gift ideas click here
RSS graphic XML Graphic

AI tool developed to identify aggressive ovarian cancer

Monday January 14th, 2019

A new artificial intelligence tool has been devised to scan the shapes of tumour cells and improve diagnosis of aggressive ovarian cancer, it has been announced.

Created by scientists at the Institute of Cancer Research, London, UK, the tool could help to tailor treatment to suit the needs of individual women.

The AI tool looks for clusters of cells within tumours with misshapen nuclei, which is an indication that the DNA of cancer cells had become unstable.

Cancers with misshapen cell nuclei had hidden weaknesses in their ability to repair DNA, which could make them susceptible to drugs called PARP inhibitors or platinum chemotherapy.

The researchers also found that immune cells were not able to move into the clusters of cells with misshapen nuclei, suggesting that cancers with these clusters are better at evading the immune system.

Women with these clusters of shapeshifting cells had an extremely aggressive type of ovarian cancer, with survival for five years or more being 15%, compared with 53% for other patients with the disease, the researchers report.

Writing in Nature Communications, the ICR team describe how they applied the AI tool to analyse tissue samples from 514 women with ovarian cancer, and it looked at almost 150 million cells.

They found tumours containing clusters of cells whose nuclei varied in shape had lower levels of activity of key DNA repair genes, including BRCA1.

The team also found that the clusters had higher levels of galectin-3 protein, which is known to cause key immune cells to die.

Dr Yinyin Yuan, team leader in computational pathology at The Institute of Cancer Research, London, said: “Using this new test gives us a way of detecting tumours with hidden weaknesses in their ability to repair DNA that wouldn’t be identified through genetic testing. It could be used alongside gene testing to identify women who could benefit from alternative treatment options that target DNA repair defects, such as PARP inhibitors.

“Our test also revealed that ovarian tumours with these clusters of misshapen nuclei have evolved a new way of evading the immune system, and it might be possible to target this mechanism with new forms of immunotherapy.”

Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, added: “What makes this test even more exciting is its ability to pick out in a new and different way those women whose tumours have weaknesses in DNA repair – who might therefore respond to treatments that target these weaknesses.”

Nature Communications 12 January 2019

Tags: Cancer | UK News | Women's Health & Gynaecology

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)